Published in Exp Physiol on October 02, 2009
Biochemical competition makes fatty-acid β-oxidation vulnerable to substrate overload. PLoS Comput Biol (2013) 0.93
Optimal experiment design for model selection in biochemical networks. BMC Syst Biol (2014) 0.83
Combined in vivo and in silico investigations of activation of glycolysis in contracting skeletal muscle. Am J Physiol Cell Physiol (2012) 0.81
Parameter trajectory analysis to identify treatment effects of pharmacological interventions. PLoS Comput Biol (2013) 0.80
Systems biology from micro-organisms to human metabolic diseases: the role of detailed kinetic models. Biochem Soc Trans (2010) 0.80
Computational modeling of mitochondrial energy transduction. Crit Rev Biomed Eng (2011) 0.78
Unchanged muscle fiber conduction velocity relates to mild acidosis during exhaustive bicycling. Eur J Appl Physiol (2011) 0.76
Improved method for accurate and efficient quantification of MRS data with use of prior knowledge J Magn Reson (1997) 6.84
Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values. Scand J Clin Lab Invest (1974) 4.79
Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study. Mol Biol Med (1983) 3.40
Can yeast glycolysis be understood in terms of in vitro kinetics of the constituent enzymes? Testing biochemistry. Eur J Biochem (2000) 3.33
ENZYME PATTERNS IN HUMAN TISSUES. I. METHODS FOR THE DETERMINATION OF GLYCOLYTIC ENZYMES. Cancer Res (1964) 3.00
Binding of glycolytic enzymes to structure proteins of the muscle. Eur J Biochem (1968) 2.91
Computer modeling of mitochondrial tricarboxylic acid cycle, oxidative phosphorylation, metabolite transport, and electrophysiology. J Biol Chem (2007) 2.61
Metabolic channeling in plants. Annu Rev Plant Biol (2004) 2.56
An integrated model of cardiac mitochondrial energy metabolism and calcium dynamics. Biophys J (2003) 2.52
The efficiency and plasticity of mitochondrial energy transduction. Biochem Soc Trans (2005) 2.24
Separate measures of ATP utilization and recovery in human skeletal muscle. J Physiol (1993) 2.13
A biophysical model of the mitochondrial respiratory system and oxidative phosphorylation. PLoS Comput Biol (2005) 2.05
Hexokinases. Rev Physiol Biochem Pharmacol (1995) 2.03
Protein-protein interaction and enzymatic activity. Annu Rev Biochem (1971) 1.84
Energetics of human muscle: exercise-induced ATP depletion. Magn Reson Med (1986) 1.83
Evolution of glycolysis. Prog Biophys Mol Biol (1993) 1.82
Minimal model of beta-cell mitochondrial Ca2+ handling. Am J Physiol (1997) 1.80
Control of glycolysis in cerebral cortex slices. Biochem J (1967) 1.74
The value of G degrees for the hydrolysis of ATP. Biochim Biophys Acta (1972) 1.73
The signal transduction function for oxidative phosphorylation is at least second order in ADP. J Biol Chem (1996) 1.43
Human muscle metabolism during sprint running. J Appl Physiol (1985) (1986) 1.42
Redox state and lactate accumulation in human skeletal muscle during dynamic exercise. Biochem J (1987) 1.38
A computational model for glycogenolysis in skeletal muscle. Ann Biomed Eng (2002) 1.28
Studies with a reconstituted muscle glycolytic system. The rate and extent of creatine phosphorylation by anaerobic glycolysis. Biochem J (1973) 1.28
The allosteric regulation of pyruvate kinase. J Biol Chem (2000) 1.27
Evaluation of exercise and training on muscle lipid metabolism. Am J Physiol (1999) 1.26
The metabolic responses of human type I and II muscle fibres during maximal treadmill sprinting. J Physiol (1994) 1.26
Human muscle glycogen resynthesis after exercise: insulin-dependent and -independent phases. J Appl Physiol (1985) (1994) 1.20
Absence of phosphocreatine resynthesis in human calf muscle during ischaemic recovery. Biochem J (1993) 1.19
Nitric oxide synthase inhibition reduces leg glucose uptake but not blood flow during dynamic exercise in humans. Diabetes (1999) 1.18
Isozymes of pyruvate kinase in vertebrates: their physical, chemical, kinetic and immunological properties. Int J Biochem (1978) 1.18
Dynamics of muscle glycogenolysis modeled with pH time course computation and pH-dependent reaction equilibria and enzyme kinetics. Biophys J (2006) 1.17
Control of glycolysis in contracting skeletal muscle. II. Turning it off. Am J Physiol Endocrinol Metab (2002) 1.14
Studies of the biochemistry of contracting and relaxing muscle by the use of 31P n.m.r. in conjunction with other techniques. Philos Trans R Soc Lond B Biol Sci (1980) 1.13
Hexokinase of human erythrocytes. Purification, kinetic model and its application to the conditions in the cell. Eur J Biochem (1974) 1.11
Computational modeling of physiological systems. Physiol Genomics (2005) 1.10
An MR-compatible bicycle ergometer for in-magnet whole-body human exercise testing. Magn Reson Med (2010) 1.10
Leg glucose uptake during maximal dynamic exercise in humans. Am J Physiol (1986) 1.08
Intersubject differences in the effect of acidosis on phosphocreatine recovery kinetics in muscle after exercise are due to differences in proton efflux rates. Am J Physiol Cell Physiol (2007) 1.04
Cellular energetics analysis by a mathematical model of energy balance: estimation of parameters in human skeletal muscle. Am J Physiol Cell Physiol (2000) 1.04
NADH in human skeletal muscle during short-term intense exercise. Pflugers Arch (1985) 1.02
Conversion of non-allosteric pyruvate kinase isozyme into an allosteric enzyme by a single amino acid substitution. J Biol Chem (1997) 1.01
Control of glycolysis in contracting skeletal muscle. I. Turning it on. Am J Physiol Endocrinol Metab (2002) 1.01
In vivo ATP synthesis rates in single human muscles during high intensity exercise. J Physiol (1999) 1.00
Flux control and excess capacity in the enzymes of glycolysis and their relationship to flight metabolism in Drosophila melanogaster. Proc Natl Acad Sci U S A (2006) 0.97
Mitochondrial calcium signaling and energy metabolism. Ann N Y Acad Sci (2005) 0.92
Regulation of glycolysis in intermittent exercise in man. J Physiol (1978) 0.92
31P-NMR observation of free ADP during fatiguing, repetitive contractions of murine skeletal muscle lacking AK1. Am J Physiol Cell Physiol (2005) 0.91
Muscle net glucose uptake and glucose kinetics after endurance training in men. Am J Physiol (1999) 0.90
ENZYME PATTERNS IN HUMAN TISSUES. II. GLYCOLYTIC ENZYME PATTERNS IN NONMALIGNANT HUMAN TISSUES. Cancer Res (1964) 0.90
G-1,6-P2 in human skeletal muscle after isometric contraction. Am J Physiol (1988) 0.88
Metabolic dynamics in skeletal muscle during acute reduction in blood flow and oxygen supply to mitochondria: in-silico studies using a multi-scale, top-down integrated model. PLoS One (2008) 0.88
Modulation of 6-phosphofructo-1-kinase oligomeric equilibrium by calmodulin: formation of active dimers. Mol Genet Metab (2005) 0.85
Effects of gender on resting leg blood flow: implications for measurement of regional substrate oxidation. J Appl Physiol (1985) (1998) 0.84
Recovery of free ADP, Pi, and free energy of ATP hydrolysis in human skeletal muscle. J Appl Physiol (1985) (1998) 0.84
Calmodulin upregulates skeletal muscle 6-phosphofructo-1-kinase reversing the inhibitory effects of allosteric modulators. Biochim Biophys Acta (2009) 0.83
Leg glucose and protein metabolism during an acute bout of resistance exercise in humans. J Appl Physiol (1985) (2004) 0.83
pH effects on oxidative phosphorylation of rat liver mitochondria. Am J Physiol (1972) 0.82
Robust homeostatic control of quadriceps pH during natural locomotor activity in man. FASEB J (2004) 0.81
The changes in the energy metabolism of human muscle induced by training. J Theor Biol (2007) 0.81
Postprandial triacylglycerol uptake in the legs is increased during exercise and post-exercise recovery. J Physiol (2005) 0.81
Resting oxygen consumption and in vivo ADP are increased in myopathy due to complex I deficiency. Neurology (2002) 0.80
Altered allosteric properties of cytoskeleton-bound phosphofructokinase in muscle from mice with X chromosome-linked muscular dystrophy (mdx). Biochem Med Metab Biol (1991) 0.77
Fitting cytosolic ADP recovery after exercise with a step response function. Magn Reson Med (1999) 0.76
The role of collagen in bone apatite formation in the presence of hydroxyapatite nucleation inhibitors. Nat Mater (2010) 2.69
Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed (2006) 2.57
1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology (2006) 2.26
MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle. FASEB J (2005) 2.03
Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett (2006) 1.98
In vivo characterization of a new abdominal aortic aneurysm mouse model with conventional and molecular magnetic resonance imaging. J Am Coll Cardiol (2011) 1.65
Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity. J Control Release (2010) 1.63
Improved biocompatibility and pharmacokinetics of silica nanoparticles by means of a lipid coating: a multimodality investigation. Nano Lett (2008) 1.62
Determination of mouse skeletal muscle architecture using three-dimensional diffusion tensor imaging. Magn Reson Med (2005) 1.60
Diffusion tensor imaging of left ventricular remodeling in response to myocardial infarction in the mouse. NMR Biomed (2009) 1.51
A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjug Chem (2004) 1.47
Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging. JACC Cardiovasc Imaging (2011) 1.46
Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. Acc Chem Res (2009) 1.42
Paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core: a new contrast agent platform for multimodality imaging. Bioconjug Chem (2008) 1.37
Molecular imaging of tumor angiogenesis using alphavbeta3-integrin targeted multimodal quantum dots. Angiogenesis (2008) 1.37
DTI-based assessment of ischemia-reperfusion in mouse skeletal muscle. Magn Reson Med (2006) 1.35
Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat. J Cereb Blood Flow Metab (2003) 1.33
Magnetic and fluorescent nanoparticles for multimodality imaging. Nanomedicine (Lond) (2007) 1.28
Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis. Mol Pharm (2010) 1.28
Skeletal muscle degeneration and regeneration after femoral artery ligation in mice: monitoring with diffusion MR imaging. Radiology (2007) 1.27
Dynamic MRS and MRI of skeletal muscle function and biomechanics. NMR Biomed (2006) 1.27
Oxidative ATP synthesis in skeletal muscle is controlled by substrate feedback. Am J Physiol Cell Physiol (2006) 1.25
Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG-micelles. Magn Reson Med (2007) 1.25
Acute neuronal injury, excitotoxicity, and the endocannabinoid system. Mol Neurobiol (2002) 1.24
Early in vivo assessment of angiostatic therapy efficacy by molecular MRI. FASEB J (2007) 1.23
A high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imaging. Eur J Pharm Biopharm (2008) 1.23
Pathway complexity in supramolecular polymerization. Nature (2012) 1.21
Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption. J Cereb Blood Flow Metab (2003) 1.21
MRI contrast agents: current status and future perspectives. Anticancer Agents Med Chem (2007) 1.19
Role of ischemia and deformation in the onset of compression-induced deep tissue injury: MRI-based studies in a rat model. J Appl Physiol (1985) (2007) 1.19
Comparison between prospective and retrospective triggering for mouse cardiac MRI. NMR Biomed (2007) 1.19
Increased intramyocellular lipid content but normal skeletal muscle mitochondrial oxidative capacity throughout the pathogenesis of type 2 diabetes. FASEB J (2008) 1.17
Synergistic targeting of alphavbeta3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis. Nano Lett (2010) 1.16
Annexin A5-conjugated quantum dots with a paramagnetic lipidic coating for the multimodal detection of apoptotic cells. Bioconjug Chem (2006) 1.14
Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation. J Nucl Med (2011) 1.13
Mathematical modeling confirms the length-dependency of telomere shortening. Mech Ageing Dev (2004) 1.10
An MR-compatible bicycle ergometer for in-magnet whole-body human exercise testing. Magn Reson Med (2010) 1.10
Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis. Bioconjug Chem (2006) 1.07
Magnetic resonance imaging in experimental models of brain disorders. J Cereb Blood Flow Metab (2003) 1.05
Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis. Angiogenesis (2010) 1.05
Three-compartment T1 relaxation model for intracellular paramagnetic contrast agents. Magn Reson Med (2009) 1.05
Intersubject differences in the effect of acidosis on phosphocreatine recovery kinetics in muscle after exercise are due to differences in proton efflux rates. Am J Physiol Cell Physiol (2007) 1.04
A unified theory for osteonal and hemi-osteonal remodeling. Bone (2007) 1.04
Intramyocellular lipid content and molecular adaptations in response to a 1-week high-fat diet. Obes Res (2005) 1.04
Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques. Bioconjug Chem (2010) 1.04
Effects of allopurinol and deferoxamine on reperfusion injury of the brain in newborn piglets after neonatal hypoxia-ischemia. Pediatr Res (2003) 1.03
Evaluation of manual and automatic segmentation of the mouse heart from CINE MR images. J Magn Reson Imaging (2008) 1.03
Dynamic behavior of fully solvated beta2-adrenergic receptor, embedded in the membrane with bound agonist or antagonist. Proc Natl Acad Sci U S A (2006) 1.03
Functional MRI reveals declined prefrontal cortex activation in patients with epilepsy on topiramate therapy. Epilepsy Behav (2006) 1.01
Block-copolymer-stabilized iodinated emulsions for use as CT contrast agents. Biomaterials (2010) 1.01
Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin. JACC Cardiovasc Imaging (2012) 1.00
Poly(ADP-ribose) polymerase regulates myocardial calcium handling in doxorubicin-induced heart failure. Biochem Pharmacol (2005) 0.99
Reproducibility of diffusion tensor imaging in human forearm muscles at 3.0 T in a clinical setting. Magn Reson Med (2010) 0.99
Reproducibility of quantitative cerebral T2 relaxometry, diffusion tensor imaging, and 1H magnetic resonance spectroscopy at 3.0 Tesla. Invest Radiol (2007) 0.99
Cellular compartmentalization of internalized paramagnetic liposomes strongly influences both T1 and T2 relaxivity. Magn Reson Med (2009) 0.98
Adaptations in mitochondrial function parallel, but fail to rescue, the transition to severe hyperglycemia and hyperinsulinemia: a study in Zucker diabetic fatty rats. Obesity (Silver Spring) (2009) 0.98
Mechanoelectric feedback leads to conduction slowing and block in acutely dilated atria: a modeling study of cardiac electromechanics. Am J Physiol Heart Circ Physiol (2007) 0.98
In vivo 1H magnetic resonance spectroscopy, T2-weighted and diffusion-weighted MRI during lithium-pilocarpine-induced status epilepticus in the rat. Brain Res (2004) 0.97
Diffusion-tensor MRI reveals the complex muscle architecture of the human forearm. J Magn Reson Imaging (2012) 0.97
The influence of temporal resolution in determining pharmacokinetic parameters from DCE-MRI data. Magn Reson Med (2010) 0.97
Three-dimensional T1 mapping of the mouse heart using variable flip angle steady-state MR imaging. NMR Biomed (2010) 0.96
Magnitude and control of mitochondrial sensitivity to ADP. Am J Physiol Endocrinol Metab (2009) 0.96
On the identifiability of pharmacokinetic parameters in dynamic contrast-enhanced imaging. Magn Reson Med (2007) 0.96
Differential effects of short- and long-term high-fat diet feeding on hepatic fatty acid metabolism in rats. Biochim Biophys Acta (2011) 0.96
Magnetic quantum dots for multimodal imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 0.95
Construction of 3D models of the CYP11B family as a tool to predict ligand binding characteristics. J Comput Aided Mol Des (2007) 0.95
DTI of human skeletal muscle: the effects of diffusion encoding parameters, signal-to-noise ratio and T2 on tensor indices and fiber tracts. NMR Biomed (2013) 0.95
Prediction of muscle energy states at low metabolic rates requires feedback control of mitochondrial respiratory chain activity by inorganic phosphate. PLoS One (2012) 0.95
Amide proton transfer imaging of high intensity focused ultrasound-treated tumor tissue. Magn Reson Med (2013) 0.94
Quantifying the composition of human skin for glucose sensor development. J Diabetes Sci Technol (2010) 0.94
Liposome-enhanced MRI of neointimal lesions in the ApoE-KO mouse. Magn Reson Med (2006) 0.93
Mouse myocardial first-pass perfusion MR imaging. Magn Reson Med (2010) 0.93
Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis. NMR Biomed (2007) 0.93
Neuroprotection by selective nitric oxide synthase inhibition at 24 hours after perinatal hypoxia-ischemia. Stroke (2002) 0.93
Altered calcium handling is an early sign of streptozotocin-induced diabetic cardiomyopathy. Int J Mol Med (2006) 0.93
Dual-targeting of αvβ3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo. J Control Release (2011) 0.92
Improved magnetic resonance molecular imaging of tumor angiogenesis by avidin-induced clearance of nonbound bimodal liposomes. Neoplasia (2008) 0.92
Internalization of annexin A5-functionalized iron oxide particles by apoptotic Jurkat cells. Contrast Media Mol Imaging (2009) 0.92
Intra-voxel heterogeneity influences the dose prescription for dose-painting with radiotherapy: a modelling study. Phys Med Biol (2009) 0.92
Distribution of lipid-based nanoparticles to infarcted myocardium with potential application for MRI-monitored drug delivery. J Control Release (2012) 0.91
In vivo excitotoxicity induced by ouabain, a Na+/K+-ATPase inhibitor. J Cereb Blood Flow Metab (2003) 0.90
Quantification of left ventricular volumes and ejection fraction in mice using PET, compared with MRI. J Nucl Med (2008) 0.90
Chitosan-based systems for molecular imaging. Adv Drug Deliv Rev (2009) 0.90
Parameter adaptations during phenotype transitions in progressive diseases. BMC Syst Biol (2011) 0.90
MRI-determined carotid artery flow velocities and wall shear stress in a mouse model of vulnerable and stable atherosclerotic plaque. MAGMA (2010) 0.89
Fasting-induced myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice is accompanied by impaired left ventricular function. Circ Cardiovasc Imaging (2011) 0.89
Surface modification of PLGA nanospheres with Gd-DTPA and Gd-DOTA for high-relaxivity MRI contrast agents. Biomaterials (2010) 0.89
Exercise training improves glycemic control in long-standing insulin-treated type 2 diabetic patients. Diabetes Care (2007) 0.89
Contrast enhancement by differently sized paramagnetic MRI contrast agents in mice with two phenotypes of atherosclerotic plaque. Contrast Media Mol Imaging (2010) 0.88
Quantitative first-pass perfusion MRI of the mouse myocardium. Magn Reson Med (2012) 0.88